Actinium Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ATNM?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	158,140	0.507%
Institutions	9,984,679	32%
General Public	21,053,072	67.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 29.18% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.21%	BlackRock, Inc.	1,938,558	US$2.2m	3.37%	no data
5.21%	The Vanguard Group, Inc.	1,625,000	US$1.9m	9.86%	no data
2.47%	District 2 Capital LP	769,452	US$892.6k	-6.89%	8.87%
2.2%	Geode Capital Management, LLC	686,153	US$795.9k	2.98%	no data
1.93%	State Street Global Advisors, Inc.	602,649	US$699.1k	-1.15%	no data
1.45%	Acadian Asset Management LLC	453,694	US$526.3k	0%	no data
1.15%	AQR Capital Management, LLC	358,812	US$416.2k	0%	no data
0.81%	Medical Strategy GmbH, Asset Management Arm	253,465	US$294.0k	0%	0.02%
0.77%	Northern Trust Global Investments	240,118	US$278.5k	5.1%	no data
0.76%	Bigger Capital, LLC	235,691	US$273.4k	-46.6%	1.27%
0.69%	Qube Research & Technologies Ltd	215,690	US$250.2k	0%	no data
0.55%	SEI Investments Management Corporation	172,070	US$199.6k	60.4%	no data
0.55%	Los Angeles Capital Management LLC	171,180	US$198.6k	0%	no data
0.54%	Verition Fund Management LLC	166,957	US$193.7k	18.8%	no data
0.51%	Millennium Management LLC	160,123	US$185.7k	661%	no data
0.48%	Michael Bigger	150,170	US$174.2k	-76.1%	no data
0.47%	Squarepoint OPS LLC	146,103	US$169.5k	204%	no data
0.46%	XTX Holdings Limited, Asset Management Arm	142,493	US$165.3k	0%	0.01%
0.41%	Renaissance Technologies LLC	127,000	US$147.3k	561%	no data
0.32%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	99,346	US$115.2k	-41.6%	no data
0.29%	Brandywine Global Investment Management, LLC	89,700	US$104.1k	-30%	no data
0.27%	Morgan Stanley, Investment Banking and Brokerage Investments	84,237	US$97.7k	-6.07%	no data
0.25%	Bridgeway Capital Management, LLC	77,000	US$89.3k	0%	no data
0.23%	Charles Schwab Investment Management, Inc.	72,093	US$83.6k	0%	no data
0.21%	BNY Asset Management	65,526	US$76.0k	-24.2%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/02 09:27
End of Day Share Price	2025/01/31 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Actinium Pharmaceuticals, Inc. is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yuan Zhi	B. Riley Securities, Inc.
George Zavoico	B. Riley Securities, Inc.
John Newman	Canaccord Genuity